Suggestions
Amanda Shaffer
Senior Medical Science Liaison at Genentech
Professional Background
Amanda Shaffer is a dedicated clinical research professional with extensive experience managing phase I-III clinical research trials specializing in oncology, virology, and inflammation at a leading pharmaceutical company. With a proven track record in the field of clinical research, Amanda excels at leading and supporting cross-functional teams, leveraging operational expertise and scientific knowledge to assure clinical trials are conducted efficiently while adhering to the highest quality standards. Her commitment to excellence is evident as she consistently meets and exceeds study deliverables aligned with the clinical development plan.
Education and Achievements
Amanda pursued her Doctor of Pharmacy at Ohio Northern University, where she gained a solid educational foundation that has empowered her career in pharmaceutical sciences. Her academic journey equipped her with essential skills, understanding, and a passion for clinical research, cultivating her ability to contribute significantly to the development of innovative therapeutics in oncology and hematology.
Notable Positions
Throughout her career, Amanda has held numerous pivotal positions. Currently, she serves as the Senior Medical Science Liaison in Malignant Hematology at Genentech. In this role, she engages with various stakeholders to bridge the gap between clinical research and practical application in patient care, ensuring that scientific data translates effectively into innovative treatment options. Prior to her tenure at Genentech, Amanda was a Medical Science Liaison in Malignant Hematology at AstraZeneca, where she became adept at disseminating complex scientific information and fostering relationships with healthcare providers.
Amanda also gained invaluable experience during her time at Gilead Sciences, initially as a Senior Clinical Trial Management Associate, and later advancing through various roles including Senior Medical Affairs Associate and Medical Scientist in Oncology Medical Affairs. Each of these roles enabled her to deepen her knowledge of clinical operations and scientific communication, preparing her for her present endeavors in malignant hematology.
Furthermore, Amanda’s foundational clinical research experience began with her tenure as a Clinical Operations Post-Doctoral Pharm.D. Fellow at Roche Pharmaceuticals. During this time, she honed her skills in managing clinical trials and ensuring compliance with regulatory standards. Her internship experience at Roxane Laboratories as a Rotating PharmD. Candidate and her time as a Pharmacy Intern at Rite Aid Pharmacy laid the groundwork for her career in pharmaceutical sciences, reinforcing her understanding of the healthcare landscape and the importance of research in patient outcomes.
Achievements
Amanda's career is marked by notable achievements that underscore her dedication to advancing clinical research. She has played an integral role in numerous clinical trials, contributing significantly to the approval of various oncology therapeutics that have transformed patient care. Her expertise in managing intricate research processes exemplifies her commitment to revolutionizing treatment pathways in oncology and hematology.
Her leadership in cross-functional teams highlights her ability to bring together diverse expertise, fostering collaboration and innovation throughout the clinical research lifecycle. Amanda’s proficiency in operational strategies ensures that clinical trials achieve their objectives efficiently while adhering to regulatory compliance and high quality standards.
In addition, Amanda's strong communication skills facilitate ongoing education within the clinical research community, helping to disseminate crucial information related to new findings and therapeutics pertinent to malignant hematology. Her role as a Senior Medical Science Liaison allows her to advocate for patients' needs while contributing to scientific discourse on treatment advancements in her field. These achievements speak volumes about her profound impact in clinical research and her passion for improving patient outcomes through innovative therapeutic strategies.